Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3546 |
|
| Actual shortage: | 240 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3292 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DOMPERIDONE | 10MG | TABLET | Resolved | 2018-03-13 | 2018-04-16 | 42686 |
| APO-DOMPERIDONE | 10MG | TABLET | Resolved | 2018-12-05 | 2018-12-21 | 68719 |
| APO-DOMPERIDONE | 10MG | TABLET | Resolved | 2019-01-23 | 2019-08-26 | 73311 |
| APO-DONEPEZIL | 5MG | TABLET | Resolved | 2017-04-04 | 2017-07-24 | 5402 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2017-05-10 | 2017-10-04 | 9928 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2018-05-01 | 2018-09-09 | 47649 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2020-08-19 | 2020-10-26 | 122477 |
| APO-DONEPEZIL | 5MG | TABLET | Resolved | 2021-05-25 | 2021-08-06 | 139834 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2021-09-17 | 2021-09-27 | 145834 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2022-03-04 | 2022-03-09 | 156033 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2024-02-23 | 2024-05-03 | 220441 |
| APO-DONEPEZIL | 5MG | TABLET | Resolved | 2024-06-06 | 2024-09-13 | 229779 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2025-06-26 | 2025-07-18 | 261167 |
| APO-DONEPEZIL | 10MG | TABLET | Actual shortage | 2025-08-07 | 2025-09-25 | 264543 |
| APO-DONEPEZIL | 5MG | TABLET | Actual shortage | 2025-11-20 | 2025-11-20 | 272347 |
| APO-DORZO-TIMOP | 5MG 20MG | SOLUTION | Resolved | 2017-03-10 | 2019-07-13 | 290 |
| APO-DORZO-TIMOP | 5MG 20MG | SOLUTION | Resolved | 2019-09-25 | 2020-09-04 | 94737 |
| APO-DORZO-TIMOP | 5MG 20MG | SOLUTION SOLUTION | Resolved | 2022-05-20 | 2022-08-06 | 161037 |
| APO-DORZO-TIMOP | 5MG 20MG | SOLUTION SOLUTION | Resolved | 2023-02-16 | 2023-02-23 | 185036 |
| APO-DORZO-TIMOP | 5MG 20MG | SOLUTION SOLUTION | Resolved | 2023-09-22 | 2023-11-24 | 205015 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |